rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

INDEX VENTURES LIFE VI (JERSEY) L.P.

10% owner

Company insider

Files Form 4 as: 10% owner, Centessa Pharmaceuticals.

In numbers

Trades disclosed
4
Buys
0
Sells
1
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
24 Jun 2026
Last trade
24 Jun 2026
Last filed
24 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
Centessa Pharmaceuticals10% owner · Biotechnology · last 24 Jun 20260 buys · 1 sell

Activity over time

1 Jun – 1 Oct
10Jun 26Jul 26Aug 26Sep 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
24 Jun 2026filed 24 Jun 2026Centessa PharmaceuticalsBiotechnologySEC FORM 4 Sold—9,812,368filing
24 Jun 2026filed 24 Jun 2026Centessa PharmaceuticalsBiotechnologySEC FORM 4 Sold—149,421filing
24 Jun 2026filed 24 Jun 2026Centessa PharmaceuticalsSEC FORM 4 Sold—9,812,368filing
24 Jun 2026filed 24 Jun 2026Centessa PharmaceuticalsSEC FORM 4 Sold—149,421filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1
Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Mary Lynne HedleyDirector · Director at Centessa Pharmaceuticals, filing Form 4 there in the last year
Brett I. W. ZbarDirector · Director at Centessa Pharmaceuticals, filing Form 4 there in the last year
Gregory M. WeinhoffChief Business Officer · Chief Business Officer at Centessa Pharmaceuticals, filing Form 4 there in the last year
John J. CrowleyChief Financial Officer · Chief Financial Officer at Centessa Pharmaceuticals, filing Form 4 there in the last year
Francesco De RubertisDirector · Director at Centessa Pharmaceuticals, filing Form 4 there in the last year